voriconazole has been researched along with fludarabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Holyoake, TL; McQuaker, IG; Osborne, WL; Parker, AN | 1 |
| Araoka, H; Asano-Mori, Y; Hayashi, M; Ishiwata, K; Ito, T; Izutsu, K; Kaji, D; Makino, S; Masuoka, K; Matsuno, N; Nishida, A; Ota, H; Takagi, S; Taniguchi, S; Tsuji, M; Uchida, N; Uchida, Y; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A | 1 |
3 other study(ies) available for voriconazole and fludarabine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Fatal peripheral neuropathy following FLA chemotherapy.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vidarabine; Voriconazole | 2004 |
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cord Blood Stem Cell Transplantation; Drug Interactions; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Premedication; Prospective Studies; Risk Factors; Transplantation Conditioning; Vidarabine; Voriconazole; Young Adult | 2014 |